An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation--a case study with CDK2/cyclinA.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European journal of medicinal chemistry

• Publication date

  2008-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJMECH.2007.10.016PMID 18037537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Consensus Scoring Strategies for Evaluating Computational Models of Protein-Ligand Complexes

  2006cited by this paper
• 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization.

  2005cited by this paper
• Virtual screening to enrich a compound collection with CDK2 inhibitors using docking, scoring, and composite scoring models

  2005cited by this paper
• LigScore: a novel scoring function for predicting binding affinities.

  2005cited by this paper
• Mammalian cyclin-dependent kinases.

  2005cited by this paper
• Evaluation of docking performance: comparative data on docking algorithms.

  2004cited by this paper
• 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding.

  2004cited by this paper
• An Introduction to Chemoinformatics

  2003cited by this paper
• Comparison of Ranking Methods for Virtual Screening in Lead-Discovery Programs

  2003cited by this paper
• Small molecules as inhibitors of cyclin-dependent kinases.

  2003cited by this paper
• CDK inhibitors in clinical development for the treatment of cancer

  2003cited by this paper
• Beware of q2!

  2002cited by this paper
• Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.

  2002cited by this paper
• Perspectives for cancer therapies with cdk2 inhibitors.

  2001cited by this paper
• Cyclin-dependent kinases.

  2001cited by this paper
• The Pezcoller lecture: cancer cell cycles revisited.

  2000cited by this paper
• Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Rational drug design : novel methodology and practical applications

  1999cited by this paper
• A general and fast scoring function for protein-ligand interactions: a simplified potential approach.

  1999cited by this paper
• Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs

  1998cited by this paper
• On the Use of Chemical Function-Based Alignments as Input for 3D-QSAR

  1998cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Cyclin-dependent kinases: engines, clocks, and microprocessors.

  1997cited by this paper
• Scoring noncovalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities

  1996cited by this paper
• BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY

  1996cited by this paper
• Poling: Promoting conformational variation

  1995cited by this paper
• Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming.

  1995cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

  1994cited by this paper
• Derivation of class II force fields. I. Methodology and quantum force field for the alkyl functional group and alkane molecules

  1994cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper
• ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES

  1980cited by this paper
• Three-Dimensional Pharmacophoric Pattern Searching

  1977cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Targeting the Cyclin-Dependent Kinase Family in Anticancer Drug Discovery: From Computational to Experimental Studies

  2024cites this paper
• UPLC-Q-Exactive Orbitrap-MS and network pharmacology for deciphering the active compounds and mechanisms of stir-fried Raphani Semen in treating functional dyspepsia

  2024cites this paper
• Elucidation of active ingredients and mechanism of action of hawthorn in the prevention and treatment of atherosclerosis.

  2022cites this paper
• Novel imidazo[2,1‐b]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation

  2021cites this paper
• Identification of potential inhibitors for Klebsiella pneumoniae carbapenemase-3: a molecular docking and dynamics study

  2019cites this paper
• Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors.

  2019cites this paper
• Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors

  2019cites this paper
• Synthesis, Structure Elucidation and Biological Activities of Some Novel 4(3H)-Quinazolinones as Anti-Biofilm Agents

  2019cites this paper
• New Isoindole‐1,3‐dione Substituted Sulfonamides as Potent Inhibitors of Carbonic Anhydrase and Acetylcholinesterase: Design, Synthesis, and Biological Evaluation

  2019cites this paper
• Design, Synthesis, and Characterization of Quinoxaline Derivatives as a Potent Antimicrobial Agent

  2018cites this paper
• Design, Synthesis, SAR and Molecular Modeling Studies of Novel Imidazo[2,1‐b][1,3,4]Thiadiazole Derivatives as Highly Potent Antimicrobial Agents

  2018cites this paper
• An integrated approach towards the development of novel antifungal agents containing thiadiazole: synthesis and a combined similarity search, homology modelling, molecular dynamics and molecular docking study

  2018cites this paper
• Studies on the interaction of BDE-47 and BDE-209 with acetylcholinesterase (AChE) based on the neurotoxicity through fluorescence, UV-vis spectra, and molecular docking.

  2018cites this paper
• Synthesis, molecular modeling, and biological evaluation of 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes

  2018cites this paper
• Synthesis, characterization, preliminary SAR and molecular docking study of some novel substituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as antifungal agents

  2017cites this paper
• Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.

  2016cites this paper
• The Prokaryotic Expression of Cyclin-Dependent Kinase 2, and the Establish of Its Inhibitor Screening System

  2016cites this paper
• SYNTHESIS, ANTITUMOR ACTIVITY, PHARMACOPHORE MODELING AND QSAR STUDIES OF NOVEL PYRAZOLES AND PYRAZOLO [1, 5-A] PYRIMIDINES AGAINST BREAST ADENOCARCINOMA MCF-7 CELL LINE

  2016cites this paper
• Design and synthesis of potent N-phenylpyrimidine derivatives for the treatment of skin cancer

  2016cites this paper
• FACULTAD DE FARMACIA UNIVERSIDAD COMPLUTENSE

  2015cites this paper
• The Effect of Specific Oligonucleotides on the Proliferation of Human Bone-Marrow Mesenchymal Stem Cells

  2014cites this paper
• Viral genes as oncolytic agents for cancer therapy

  2014cites this paper
• An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.

  2013cites this paper
• The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies

  2013cites this paper
• The role of 3D pharmacophore mapping based virtual screening for identification of novel anticancer agents: an overview.

  2013cites this paper
• Pharmacophore-based virtual screening.

  2011cites this paper
• Synthesis of 6-(het) ary Xylocydine analogues and evaluating their inhibitory activities of CDK1 and CDK2 in vitro.

  2011cites this paper
• Insights into the structural and conformational requirements of polybrominated diphenyl ethers and metabolites as potential estrogens based on molecular docking.

  2011cites this paper
• Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors.

  2011cites this paper
• Chemoinformatics and Computational Chemical Biology

  2011cites this paper
• PHARMACOPHORE MAPPIG - AAPPROACH FOR DESIGIG CYCLI DEPEDET KIASE 2 IHIBITORS FOR CACER TREATMET

  2010cites this paper
• Molecular Modeling Studies of 4,5-Dihydro-1H-pyrazolo[4,3-h] quinazoline Derivatives as Potent CDK2/Cyclin A Inhibitors Using 3D-QSAR and Docking

  2010cites this paper
• Comparison of Three Preprocessing Filters Efficiency in Virtual Screening: Identification of New Putative LXRβ Regulators As a Test Case

  2010cites this paper
• Molecular-docking-guided 3D-QSAR studies of substituted isoquinoline-1,3-(2H,4H)-diones as cyclin-dependent kinase 4 (CDK4) inhibitors

  2010cites this paper
• Exploring the binding features of polybrominated diphenyl ethers as estrogen receptor antagonists: docking studies

  2010cites this paper
• Computational Intelligence Methods for Docking Scores

  2009cites this paper
• Combined Ligand and Structure Based Approaches for Narrowing on the Essential Physicochemical Characteristics for CDK4 Inhibition

  2008cites this paper